The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

Medability GmbH, a German medical technology company, will establish its U.S. headquarters in Tampa. It's the latest foreign ...

The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...

ColdVentures enters exclusive distribution partnership with Medco Sports Medicine: Los Angeles Monday, January 27, 2025, 16:00 Hrs [IST] ColdVentures, a leading medical device com ...

The U.S. Food and Drug Administration (“FDA”), in partnership with the Department of Justice (“DOJ”), pursued significant and, in some ...

The FDA warned the nation about the growing vulnerability of the medical device supply chain and its effects on public health, particularly among pediatric patients, in a Jan. 16 news release.

Here are seven orthopedic and spine devices and technologies that have recently received FDA clearance, as reported by Becker's since Dec. 17: 1. SurGenTec earned FDA ... BlackArmor spine implants. 4.